Alnylam Pharmaceuticals
ALNY
#828
Rank
$31.60 B
Marketcap
$236.22
Share price
3.02%
Change (1 day)
-48.01%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company